Progress against malignant brain tumors depends on team science: shared biobanks and registries, multi-disciplinary clinical trials, and partnerships across neurosurgery, neuro-oncology, pathology, and engineering. The MLiNS lab contributes to this ecosystem through translational studies that combine prospective trial design, rich tumor biology, and rigorous data science, including work on privacy-preserving collaboration (for example, federated learning across sites) so institutions can learn together without centralizing sensitive patient data. The publications below highlight representative collaborative neuro-oncology efforts.